Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer
Clinical trial NCT00394251 · COMPLETED
Trial details
- NCT number
- NCT00394251
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-03-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.